Literature DB >> 10410189

Treatment of RSV pneumonia in adults--evidence of ribavirin effectiveness?

K D Dominguez1, R C Mercier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10410189     DOI： 10.1345/aph.18243

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  4 in total

1.  Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSs.

Authors:  Olga Lihoradova; Tetsuro Ikegami
Journal:  Future Virol       Date:  2014-01-01       Impact factor: 1.831

Review 2.  Characteristics of viral pneumonia in the COVID-19 era: an update.

Authors:  P Pagliano; C Sellitto; V Conti; T Ascione; Silvano Esposito
Journal:  Infection       Date:  2021-03-29       Impact factor: 3.553

3.  Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada.

Authors:  Sandra R Knowles; Elizabeth J Phillips; Linda Dresser; Larissa Matukas
Journal:  Clin Infect Dis       Date:  2003-09-12       Impact factor: 9.079

Review 4.  Pneumonia in the tropics.

Authors:  Tow Keang Lim; Wen Ting Siow
Journal:  Respirology       Date:  2017-08-01       Impact factor: 6.424
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.